This category covers crypto market news today, including crypto index trends, major exchange data, capital flows, sentiment shifts, regulation impact and crypto’s interaction with traditional finance. Designed to help you understand the forces driving valuation across tokens, sectors and regions.
On Friday, Tesla stock closed at $489.61, or 9.66% down. Today, at the time of writing, TSLA stock is 7% up, trading at $524.11.
Regeneron noted that the initial dose of its COVID-19 drug will be released through a federal government allocation program to approximately 300,000 patients across the country.
One of the regimens came out with 62% efficacy when administered for one month apart in two full doses. The other dosing regimen came out with an efficacy rate of 90% when administered for at least a month apart with a half dose followed by a full dose.
Western Union is confident that stc pay is poised for expansion and further growth in the future.
Pfizer is on track to deliver up to 50 million doses in 2020 and about 1.3 billion doses in 2021.
In response to the high demand in the gaming industry, Roblox recorded about $1.24 billion in sales after the first three quarters of 2020.
The government in Vietnam has threatened to shut down Facebook servers in the country if it does not agree on the new local political content terms.
At the time of writing, Macy’s (M) stock is trading at $8.90 which means that it is 1.06% down.
The S&P 500 index has been on the positive side for the better part of the pandemic. The index has gained 10.04% YtD.
The positive COVID-19 updates from Pfizer-BioNTech, Moderna, and AstraZeneca-Oxford give hope that the end is near for the COVID-19 pandemic that continues to plague our world for almost a year by now.
The move by Affirm to debut on the stock exchange through its recently announced IPO comes as one of the many public listings recorded in 2020.
Zoom shareholders anticipate experiencing a new bull wave after the shares complete the current retracement.
For the past three months, Nvidia reported revenue of $4.73 billion against $4.41 billion expected by analysts.
Nio reported an adjusted net loss of $146.7 million, in the past three months, with total revenues surging 146.4.% year-over-year to $666.6 million.
As CureVac prepares to push its COVID-19 vaccine candidate in the final stage of trials, it is also working on a pan-EU network to manufacture millions of the vaccine doses.